A Double-Blind, Randomized, Placebo-Controlled with an Open-Label Rollover Extension Phase 2/3 Clinical Trial to Evaluate Safety and Efficacy of US-APR2020 in Subjects with CKD Sta... von Ranganathan, Natarajan, Vyas, Usha N., Ranganathan, Pari, Irvin, Anthony, Weinberg, Alan D.

Volltext

Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage von García-Arroyo, Fernando E, Gonzaga, Guillermo, Muñoz-Jiménez, Itzel, Blas-Marron, Mónica G, Silverio, Octaviano, Tapia, Edilia, Soto, Virgilia, Ranganathan, Natarajan, Ranganathan, Pari, Vyas, Usha, Irvin, Anthony, Ir, Diana, Robertson, Charles E, Frank, Daniel N, Johnson, Richard J, Sánchez-Lozada, L Gabriela

Volltext

Novel volumetric imaging biomarkers for assessing disease activity in eyes with PCV von Vyas, Chinmayi Himanshuroy, Cheung, Chui Ming Gemmy, Jordan-Yu, Janice Marie N., Shimizu, Hitoshi, Tan, Anna Cheng Sim, Sim, Shaun Sebastian, Fenner, Beau James, Akiba, Masahiro, Chakravarthy, Usha, Teo, Kelvin Yi Chong

Volltext

Hospital-based sentinel surveillance for Streptococcus pneumoniae and other invasive bacterial diseases in India (HBSSPIBD): design and methodology von Rajkumar, Prabu, Bharathy, Sukumar, Girish Kumar, C P, Veeraraghavan, Balaji, Verghese, Valsan, Gupta, Nivedita, Kangusamy, Boopathi, Ravi, Muthusamy, Jayaraman, Yuvaraj, Malik, Shikha, Biswas, Debasis, Kumar, Amber, Singh, Kuldeep, Nag, Vijaya lakshmi, Sharma, Anuradha, Kumar, Prawin, Varghese, Rosemol, Kumar D, Jones Lionel, Sharma, Milap, Jharyal, S C, Sreenivasan, Priya, Sarada devi, K L, Jyothi, R, Poovazhagi, V, Devasena, N R, Benakappa, Naveen, Sathenahalli, Veeraraja B, Bhavana, J, Balasubramanian, S, Bai Perumal, Sulochana Putli, Vijay Kumar, G, Padmaja, G, Usha Rani, P, Baghel, Bhagat, Majumdar, Dev Jyoti, Baveja, Sujata, Shinde, Alka, Karnik, Prachi, Jain, Hemant, Mutha, Anitha, Mehta, Nirbhay, Vyas, Bhadresh R, Mehta, Krunal D, Chaudhry, Anil Kumar, Kumar, Manoj, Malhotra, Bharti, Saini, G S, Soodan, Shashi, Kour, Harleen

Volltext